LLY
747.85
-0.07%↓
UNH
590.82
-1.04%↓
JNJ
155.2
-0.15%↓
NVO
105.18
+2.52%↑
ABBV
177.14
+3.17%↑
LLY
747.85
-0.07%↓
UNH
590.82
-1.04%↓
JNJ
155.2
-0.15%↓
NVO
105.18
+2.52%↑
ABBV
177.14
+3.17%↑
LLY
747.85
-0.07%↓
UNH
590.82
-1.04%↓
JNJ
155.2
-0.15%↓
NVO
105.18
+2.52%↑
ABBV
177.14
+3.17%↑
LLY
747.85
-0.07%↓
UNH
590.82
-1.04%↓
JNJ
155.2
-0.15%↓
NVO
105.18
+2.52%↑
ABBV
177.14
+3.17%↑
LLY
747.85
-0.07%↓
UNH
590.82
-1.04%↓
JNJ
155.2
-0.15%↓
NVO
105.18
+2.52%↑
ABBV
177.14
+3.17%↑
24h
Current
Min
24.89
Max
25.28
Recommendations | Buy |
---|---|
12 Months Forecast | +90.3 upside |
By Acuity
50%
50%
162 / 392 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
23.62 / 27.5 Support & Resistance
Past performance is not a reliable indicator of future results.
٢٦ سبتمبر ٢٠٢٤، ٠٢:٢٠ م UTC
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. -- IBD
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 47.67 USD 90.3%
High 80 USD
Low 24 USD
Based on 11 Wall Street analysts offering 12 month price targets forBeam Therapeutics Inc - Dist in the last 3 months.
By TipRanks
Buy
11 ratings
7
Buy
4
Hold
0
Sell
Based on 11 analysts giving stock ratings to Beam Therapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Intermediate Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
$